Misapplication #1
EO as Primary Treatment: Why It Always Costs Too Much
When EO is installed as the first treatment step for wastewater with significant biodegradable COD load, the operating cost is 40–80× higher than it needs to be. This page explains the mechanism of this error and how to configure the correct treatment train. The single most expensive way to run an electrode: pointing it at a load biology was never given the chance to remove first.
Recognising it
What this actually looks like
A facility installs EO ahead of, or instead of, any biological treatment stage — usually because the project timeline favoured a single compact unit over a longer biological build-out, or because nobody ran a BOD:COD check before scoping the system. The electrode runs, the effluent looks acceptable, and the operating cost per kilogram of COD removed comes in far higher than anyone modelled.
It’s rarely framed internally as “we skipped biological treatment.” It’s usually framed as “we needed a fast, compact solution,” with the cost consequence of that choice discovered later, in the first few utility bills. Treatment train design decisions affect operating cost for the life of the system. This page describes a category of configuration error that produces a system that operates as designed but at an operating cost that cannot be sustained.
The error mechanism
EO oxidises everything — including what does not need to be oxidised
Electrochemical oxidation generates hydroxyl radicals non-selectively. They attack any oxidisable organic compound in the matrix, including readily biodegradable organics that biological treatment would have handled at a fraction of the energy cost. When EO is applied to raw or primary-settled wastewater with high BOD, the majority of the charge density consumed — and the majority of the energy cost — goes into oxidising biodegradable COD that had no need for electrochemical treatment. The trace recalcitrant compounds that justified EO deployment receive a small fraction of the available oxidant. The system treats the wrong fraction at enormous energy cost.
The root cause
Why this happens
Two pressures usually combine to produce this pattern: a compressed project timeline that makes a compact, fast-to-install technology attractive regardless of its operating cost profile, and a scoping process that never explicitly checked BOD:COD before specifying the technology. EO’s electrode chemistry doesn’t distinguish biodegradable organics from refractory ones — it will happily oxidise both — so nothing about running the pilot flags this as a problem until the full-scale operating cost arrives.
It also happens when a site inherits an EO system sized for a different, more refractory stream and later routes a higher-BOD flow through the same unit without re-checking whether that flow still fits the original economic case.
The corrected architecture
What the treatment train should look like
The correct configuration for any stream containing both biodegradable COD and recalcitrant target compounds — PFAS, 1,4-dioxane, pharmaceutical residuals — is biological pre-treatment followed by EO polishing. The biological step mineralises the biodegradable fraction at 0.3–1.0 kWh/kg COD. The biological effluent, at 30–80 mg/L residual COD, then enters the EO stage where the charge density is now consumed primarily by the recalcitrant target compound — at 10–20× lower charge density than in the raw influent, because the competing organic demand has been eliminated. Energy consumption for the EO stage on secondary effluent is 2–10 kWh/m³ instead of 40–120 kWh/m³ on raw influent.
- Biology first: 0.3–1.0 kWh/kg COD on the biodegradable fraction
- EO second: 2–10 kWh/m³ on secondary effluent vs. 40–120 kWh/m³ on raw influent
- Competing COD in secondary effluent: 30–80 mg/L vs. 2,000–10,000 mg/L in raw influent
- Charge density required for PFAS in secondary effluent: 5–15× lower than in raw influent at same PFAS concentration
- The order of treatment steps is not a preference — it is the only economically viable configuration for mixed streams
The real consequence
What it costs you
The direct cost is operating expense: paying electrochemical rates per kilogram of COD removed for load that a biological process would have handled at a fraction of that cost. Depending on concentration and target, that gap is commonly an order of magnitude or more — enough to turn a system that looked capital-efficient at the proposal stage into one that’s difficult to justify by its second year of operation.
The indirect cost is reputational, inside the organisation that approved the project: an EO system with a poor cost-per-kilogram track record makes the next legitimate EO application — one where it’s actually the right tool — harder to get approved, even though the underlying technology wasn’t the problem.
The actual fix
How to avoid or correct it
- Check BOD:COD before specifying any technology, not after a vendor has already proposed one
- If BOD:COD is above roughly 0.5, scope biological treatment first and treat EO as a question for whatever refractory fraction survives it
- If timeline is the real constraint, weigh a phased build — biological treatment now, EO polishing added later — against the full-project operating cost of skipping biology entirely
- Re-check BOD:COD any time a new or blended flow gets routed through an existing EO system
Common questions
Primary Treatment Misapplication FAQ
Yes — specifically streams where the COD is predominantly recalcitrant to biological treatment: concentrated AFFF leachate where essentially no COD is biodegradable, high-concentration cyanide solutions from electroplating rinse water where cyanide is the only significant organic parameter, or specific industrial process streams where the organic content is entirely from non-biodegradable compounds. In these cases, biological pre-treatment adds capital and operating cost without meaningful load reduction before EO. The distinction is whether the bulk COD is biodegradable — and that answer comes from biological oxygen demand testing on the specific stream. In a genuinely space- or time-constrained scenario, possibly — but that’s a deliberate trade-off of higher operating cost for faster deployment or a smaller footprint, made with eyes open, not a default scoping decision.
A biochemical oxygen demand (BOD5) test alongside a chemical oxygen demand (COD) test gives the BOD:COD ratio. A BOD:COD ratio above 0.4 indicates a primarily biodegradable stream — biological treatment is the right first step. A BOD:COD ratio below 0.1 indicates a primarily recalcitrant stream — EO may be appropriate as a primary step. Between 0.1 and 0.4, the stream has a mixed character — biological pre-treatment is usually still the more cost-effective first step for the biodegradable fraction, followed by EO for the residual. Compare current operating cost per kilogram of COD removed against a biological treatment benchmark for a similar stream. A large, persistent gap is the signal, even if the system is technically performing as designed.
Error-specific
This page addresses one specific error with a specific correction — not a general 'EO needs pre-treatment' statement.
Quantified
Energy consumption figures for the error and the corrected configuration are stated with the basis that produced them.
Correction-routed
The corrected treatment train architecture is described in enough detail to inform a revised project scope.
Where to go from here
Take the path your project supports
→ Yes — EO is a fit
Your contaminant is recalcitrant, your regulatory driver requires destruction, and the matrix is compatible. Move to treatability testing.
→ Not sure yet
You have answered some of the fit questions but not all. Use the Go / No-Go Checklist to work through the remaining decision variables.
→ No — EO is not the right fit
The contaminant is biodegradable, the scale is too large, or the driver does not require destruction. Review the alternatives.